Cargando…
Empiric Antifungal Therapy for Intra-Abdominal Post-Surgical Abscesses in Non-ICU Patients
The role of empiric antifungals for post-surgical abscesses (PSAs) is controversial, and international guidelines on invasive mycoses focus on bloodstream infections. We analyzed a retrospective cohort of 319 patients with PSA at a tertiary-level hospital in Italy during the years 2013–2018. Factors...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135368/ https://www.ncbi.nlm.nih.gov/pubmed/37107063 http://dx.doi.org/10.3390/antibiotics12040701 |
_version_ | 1785031961820004352 |
---|---|
author | Taddei, Eleonora Giovannenze, Francesca Birocchi, Emanuela Murri, Rita Cerolini, Lucia Segala, Francesco Vladimiro Del Vecchio, Pierluigi Taccari, Francesco Fantoni, Massimo |
author_facet | Taddei, Eleonora Giovannenze, Francesca Birocchi, Emanuela Murri, Rita Cerolini, Lucia Segala, Francesco Vladimiro Del Vecchio, Pierluigi Taccari, Francesco Fantoni, Massimo |
author_sort | Taddei, Eleonora |
collection | PubMed |
description | The role of empiric antifungals for post-surgical abscesses (PSAs) is controversial, and international guidelines on invasive mycoses focus on bloodstream infections. We analyzed a retrospective cohort of 319 patients with PSA at a tertiary-level hospital in Italy during the years 2013–2018. Factors associated with empiric antifungal administration were analyzed and compared with factors associated with fungal isolation from the abdomen. Forty-six patients (14.4%) received empiric antifungals (65.2% azoles). Candida was isolated in 34/319 (10.7%) cases, always with bacteria. Only 11/46 patients receiving empirical antifungals had abdominal Candida. Only 11/34 patients with a fungal isolate received empiric antifungal therapy. Upper GI surgery (OR: 4.76 (CI: 1.95–11.65), p = 0.001), an intensive care unit stay in the previous 90 days (OR: 5.01 (CI: 1.63–15.33), p = 0.005), and reintervention within 30 days (OR: 2.52 (CI: 1.24–5.13), p = 0.011) were associated with empiric antifungals in a multivariate analysis, while pancreas/biliary tract surgery was associated with fungal isolation (OR: 2.25 (CI: 1.03–4.91), p = 0.042), and lower GI surgery was protective (OR: 0.30 (CI: 0.10–0.89), p = 0.029) in a univariate analysis. The criteria for empiric antifungal therapy in our practice seem to be inconsistent with the risk factors for actual fungal isolation. Better guidance for empiric therapy should be provided by wider studies. |
format | Online Article Text |
id | pubmed-10135368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101353682023-04-28 Empiric Antifungal Therapy for Intra-Abdominal Post-Surgical Abscesses in Non-ICU Patients Taddei, Eleonora Giovannenze, Francesca Birocchi, Emanuela Murri, Rita Cerolini, Lucia Segala, Francesco Vladimiro Del Vecchio, Pierluigi Taccari, Francesco Fantoni, Massimo Antibiotics (Basel) Article The role of empiric antifungals for post-surgical abscesses (PSAs) is controversial, and international guidelines on invasive mycoses focus on bloodstream infections. We analyzed a retrospective cohort of 319 patients with PSA at a tertiary-level hospital in Italy during the years 2013–2018. Factors associated with empiric antifungal administration were analyzed and compared with factors associated with fungal isolation from the abdomen. Forty-six patients (14.4%) received empiric antifungals (65.2% azoles). Candida was isolated in 34/319 (10.7%) cases, always with bacteria. Only 11/46 patients receiving empirical antifungals had abdominal Candida. Only 11/34 patients with a fungal isolate received empiric antifungal therapy. Upper GI surgery (OR: 4.76 (CI: 1.95–11.65), p = 0.001), an intensive care unit stay in the previous 90 days (OR: 5.01 (CI: 1.63–15.33), p = 0.005), and reintervention within 30 days (OR: 2.52 (CI: 1.24–5.13), p = 0.011) were associated with empiric antifungals in a multivariate analysis, while pancreas/biliary tract surgery was associated with fungal isolation (OR: 2.25 (CI: 1.03–4.91), p = 0.042), and lower GI surgery was protective (OR: 0.30 (CI: 0.10–0.89), p = 0.029) in a univariate analysis. The criteria for empiric antifungal therapy in our practice seem to be inconsistent with the risk factors for actual fungal isolation. Better guidance for empiric therapy should be provided by wider studies. MDPI 2023-04-03 /pmc/articles/PMC10135368/ /pubmed/37107063 http://dx.doi.org/10.3390/antibiotics12040701 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Taddei, Eleonora Giovannenze, Francesca Birocchi, Emanuela Murri, Rita Cerolini, Lucia Segala, Francesco Vladimiro Del Vecchio, Pierluigi Taccari, Francesco Fantoni, Massimo Empiric Antifungal Therapy for Intra-Abdominal Post-Surgical Abscesses in Non-ICU Patients |
title | Empiric Antifungal Therapy for Intra-Abdominal Post-Surgical Abscesses in Non-ICU Patients |
title_full | Empiric Antifungal Therapy for Intra-Abdominal Post-Surgical Abscesses in Non-ICU Patients |
title_fullStr | Empiric Antifungal Therapy for Intra-Abdominal Post-Surgical Abscesses in Non-ICU Patients |
title_full_unstemmed | Empiric Antifungal Therapy for Intra-Abdominal Post-Surgical Abscesses in Non-ICU Patients |
title_short | Empiric Antifungal Therapy for Intra-Abdominal Post-Surgical Abscesses in Non-ICU Patients |
title_sort | empiric antifungal therapy for intra-abdominal post-surgical abscesses in non-icu patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135368/ https://www.ncbi.nlm.nih.gov/pubmed/37107063 http://dx.doi.org/10.3390/antibiotics12040701 |
work_keys_str_mv | AT taddeieleonora empiricantifungaltherapyforintraabdominalpostsurgicalabscessesinnonicupatients AT giovannenzefrancesca empiricantifungaltherapyforintraabdominalpostsurgicalabscessesinnonicupatients AT birocchiemanuela empiricantifungaltherapyforintraabdominalpostsurgicalabscessesinnonicupatients AT murririta empiricantifungaltherapyforintraabdominalpostsurgicalabscessesinnonicupatients AT cerolinilucia empiricantifungaltherapyforintraabdominalpostsurgicalabscessesinnonicupatients AT segalafrancescovladimiro empiricantifungaltherapyforintraabdominalpostsurgicalabscessesinnonicupatients AT delvecchiopierluigi empiricantifungaltherapyforintraabdominalpostsurgicalabscessesinnonicupatients AT taccarifrancesco empiricantifungaltherapyforintraabdominalpostsurgicalabscessesinnonicupatients AT fantonimassimo empiricantifungaltherapyforintraabdominalpostsurgicalabscessesinnonicupatients |